Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.57%94.8B | 2.84%86.52B | 2.77%21.61B | 5.99%22.29B | 5.02%22.06B | -2.42%20.56B | 4.24%84.13B | 0.52%21.03B | 0.37%21.03B | 4.92%21B |
| Cost of revenue | 7.81%82.1B | 1.09%76.15B | -0.62%18.77B | 0.91%19.45B | 4.58%19.58B | -0.53%18.36B | 9.25%75.33B | 4.26%18.89B | 7.34%19.27B | 9.67%18.72B |
| Gross profit | 22.54%12.7B | 17.82%10.37B | 32.60%2.84B | 61.65%2.85B | 8.67%2.48B | -15.81%2.2B | -25.18%8.8B | -23.59%2.14B | -41.33%1.76B | -22.60%2.28B |
| Operating expense | 8.74%8.77B | 12.74%8.07B | 13.55%2.15B | 18.58%2.02B | 10.47%1.93B | 8.61%1.97B | -4.92%7.16B | -2.07%1.9B | -9.04%1.7B | -7.12%1.75B |
| Operating profit | 71.01%3.93B | 39.98%2.3B | 180.74%685M | 1,303.39%828M | 2.80%551M | -70.95%233M | -61.22%1.64B | -71.79%244M | -94.78%59M | -49.86%536M |
| Net non-operating interest income (expenses) | -30.00%-195M | -9.49%-150M | -8.11%-40M | -12.12%-37M | -15.63%-37M | -2.86%-36M | 0.00%-137M | -8.82%-37M | 0.00%-33M | 8.57%-32M |
| Non-operating interest income | 60.00%8M | --5M | --1M | --2M | --2M | --0 | --0 | --0 | --0 | --0 |
| Non-operating interest expense | 30.97%203M | 13.14%155M | 10.81%41M | 18.18%39M | 21.88%39M | 2.86%36M | 0.00%137M | 8.82%37M | 0.00%33M | -8.57%32M |
| Net investment income | 17.98%269M | -8.80%228M | 20.00%18M | 7.87%96M | -166.67%-2M | -18.88%116M | -5.30%250M | 15.38%15M | -21.24%89M | 50.00%3M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 15,240.00%767M | -99.74%5M | -107.22%-7M | 0 | 12M | 0 | 3,016.13%1.93B | 1,840.00%97M | 77M | 0 |
| Income from associates and other participating interests | -52.15%1.54B | 71.56%3.23B | 30.69%609M | 69.13%778M | 258.00%895M | 34.04%945M | 87.72%1.88B | 1,094.87%466M | 55.41%460M | 46.20%250M |
| Special income (charges) | -817.01%-1.35B | 72.88%-147M | 100.53%2M | 61.25%-31M | -295.52%-265M | 1,018.75%147M | -134.95%-542M | -1,747.83%-379M | -1,242.86%-80M | -104.70%-67M |
| Less:Restructuring and mergern&acquisition | 122.22%620M | --279M | --98M | --181M | ---- | ---- | --0 | --0 | ---- | ---- |
| Less:Other special charges | 69.91%-102M | -218.53%-339M | -212.22%-202M | -287.50%-150M | 2,550.00%265M | -1,675.00%-252M | 117.62%286M | 289.47%180M | 1,242.86%80M | 100.70%10M |
| Less:Write off | 300.97%830M | -19.14%207M | -48.74%102M | --0 | --0 | --105M | 255.56%256M | --199M | --0 | --57M |
| Other non-operating income (expenses) | 15.14%517M | 16.32%449M | -1.08%184M | 93.02%83M | 9.09%72M | 20.88%110M | 19.50%386M | 60.34%186M | -41.89%43M | -5.71%66M |
| Income before tax | -7.24%5.48B | 9.20%5.91B | 145.10%1.45B | 179.32%1.72B | 62.17%1.23B | -56.02%1.52B | -25.87%5.41B | -42.47%592M | -61.31%614M | -72.60%756M |
| Income tax | 45.14%1.55B | -5.31%1.07B | 632.61%337M | 371.01%325M | -6.56%171M | -71.51%237M | -39.54%1.13B | -83.57%46M | -82.62%69M | -76.02%183M |
| Net income | -18.83%3.93B | 13.04%4.84B | 104.22%1.11B | 154.76%1.39B | 84.44%1.06B | -51.13%1.28B | -21.16%4.28B | -27.14%545M | -54.12%546M | -71.34%572M |
| Net income continuous operations | -18.83%3.93B | 13.03%4.84B | 104.03%1.11B | 155.05%1.39B | 84.12%1.06B | -51.09%1.28B | -21.16%4.28B | -27.10%546M | -54.20%545M | -71.29%573M |
| Noncontrolling interests | 29.03%320M | 66.44%248M | 81.05%172M | 373.33%71M | -290.00%-19M | -17.24%24M | -15.82%149M | -10.38%95M | -58.33%15M | 25.00%10M |
| Net income attributable to the company | -21.42%3.61B | 11.14%4.59B | 109.11%941M | 149.25%1.32B | 90.76%1.07B | -51.53%1.25B | -21.35%4.13B | -29.80%450M | -54.11%530M | -71.68%563M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -21.42%3.61B | 11.14%4.59B | 109.11%941M | 149.25%1.32B | 90.76%1.07B | -51.53%1.25B | -21.35%4.13B | -29.80%450M | -54.11%530M | -71.68%563M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -20.73%102.5067 | 12.28%129.3167 | 109.31%26.6167 | 147.85%37.2933 | 87.34%30.2367 | -50.65%35.17 | -12.77%115.1733 | -25.71%12.7167 | -47.71%15.0467 | -67.42%16.14 |
| Diluted earnings per share | -20.74%102.1267 | 12.26%128.8433 | 109.10%26.5133 | 147.61%37.15 | 86.93%30.1267 | -50.61%35.0533 | -12.73%114.77 | -25.62%12.68 | -47.67%15.0033 | -67.34%16.1167 |
| Dividend per share | 0.00%40 | 20.00%40 | 40.00%23.3333 | 0 | 0.00%16.6667 | 0 | -16.67%33.3333 | -28.57%16.6667 | 0 | 0.00%16.6667 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |